Hormone therapy does not need to be routinely discontinued in women aged older than 60 or 65 years and can be considered for continuation beyond age 65 years for persistent hot flashes, quality - of - life issues, or
prevention of osteoporosis after appropriate evaluation and counseling of benefits and risks.